EICHOR
● Active Not Recruiting
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
Condition: Non-small Cell Lung Cancer · Sponsor: Daiichi Sankyo
About this study
This study will evaluate the efficacy, safety, and pharmacokinetics of DS-1062a versus docetaxel in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (209)
| Ironwood Cancer and Research Center | Chandler, Arizona, United States | — |
| St. Joseph Heritage Healthcare | Anaheim, California, United States | — |
| The Oncology Institute of Hope and Innovation | Glendale, California, United States | — |
| University of California San Diego | La Jolla, California, United States | — |
| UCLA | Los Angeles, California, United States | — |
| PIH Health | Whittier, California, United States | — |
| Memorial Healthcare System- Memorial Cancer Institute | Hollywood, Florida, United States | — |
| Orlando Health | Orlando, Florida, United States | — |
| Florida Cancer Specialists | Tallahassee, Florida, United States | — |
| Northwestern University | Chicago, Illinois, United States | — |
| University of Chicago | Chicago, Illinois, United States | — |
| Ft. Wayne Medical Oncology and Hematology | Fort Wayne, Indiana, United States | — |
+ 197 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.